Market Overview

Morning Market Movers

Share:
Related ALNY
Benzinga's Top Upgrades, Downgrades For November 9, 2017
The Market In 5 Minutes: Adidas, Jobless Claims, And More
Alnylam completes U.S. marketing application for patisiran for hATTR amyloidosis (Seeking Alpha)
Related MRK
3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise
FDA Decisions In November: The Month In Review
3 Things In Biotech You Should Learn Today: December 12, 2017 (Seeking Alpha)

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

View Comments and Join the Discussion!

Partner Center